Australia's most trusted
source of pharma news
Wednesday, 01 April 2026
Posted 1 April 2026 AM
Long-time pharma industry executive Nikki Lorenz has been named as the new CEO of the Generic and Biosimilar Medicines Association (GBMA).
Lorenz brings extensive experience in pharma and healthcare to the role, with the GBMA underlining her strong track record of strategic leadership, stakeholder engagement, and advancing patient access to medicines.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.